What vitamin D level is 'low'?

The National Academies consider 50 nmol/L (20 ng/mL) or more sufficient for most people, with deficiency risk rising below 30 nmol/L (12 ng/mL). Levels above 125 nmol/L (50 ng/mL) are associated with potential harm. More is not better past sufficiency.

Should everyone take vitamin D?

The 2024 Endocrine Society guideline suggests against empiric supplementation above the recommended intake for healthy adults under 75, and against routine blood testing in the general population. It does recommend supplementation for adults 75 and older, pregnant people, children, and people with high-risk prediabetes.

When would a provider use an injection instead of a pill?

When absorption is unreliable — fat-malabsorption conditions, gastric bypass — or when adherence to daily dosing is the barrier. In a head-to-head pediatric trial, a single intramuscular dose and a staggered oral course corrected deficiency equally well; the route is a practical choice, not a stronger one.

Vitamin D: Test First, Then Decide

Why this page exists

Vitamin D is the most over-prescribed and under-tested supplement in wellness. Two things are true at once:

Real deficiency is common and worth fixing — it affects bone, muscle, and immune function.
For most healthy adults, more vitamin D has not been shown to prevent disease, and the most recent major guideline says to stop testing and dosing reflexively.

Holding both at once is the whole skill. Here is the evidence for each.

The numbers that define “low”

The National Academies “state that levels of 50 nmol/L (20 ng/mL) or more are sufficient for most people, and that the risk of deficiency increases at serum concentrations of less than 30 nmol/L (12 ng/mL)” (NIH Office of Dietary Supplements). The recommended intake for adults is 600–800 IU per day, and the Tolerable Upper Intake Level tops out at 4,000 IU per day for adults (same source). The test is a serum 25-hydroxyvitamin D, written 25(OH)D.

Who tends to run low: “older adults, people with limited sun exposure, people with dark skin, people with conditions that limit fat absorption, and people with obesity or those who have undergone gastric bypass surgery” (NIH ODS). If that describes you and you’ve never been tested, a 25(OH)D is a reasonable addition to the baseline labs a provider orders.

What the big trial found (and didn’t)

VITAL randomized 25,871 US adults to 2,000 IU of vitamin D3 daily or placebo and followed them a median of 5.3 years. The result: no reduction in invasive cancer (hazard ratio 0.96) or major cardiovascular events (0.97). The authors’ conclusion: “Supplementation with vitamin D did not result in a lower incidence of invasive cancer or cardiovascular events than placebo” (Manson et al., NEJM 2019).

That trial reshaped the guidance. The 2024 Endocrine Society guideline “suggests against routine 25(OH)D testing in all populations considered” and “suggests against empiric vitamin D supplementation above the current DRI to lower the risk of disease in healthy adults younger than 75 years.” It does recommend supplementation for children and adolescents, adults 75 and older, pregnant people, and people with high-risk prediabetes (Demay et al., J Clin Endocrinol Metab 2024).

Read carefully, the guideline isn’t anti-vitamin D. It is anti-reflex. Test when there is a reason; dose when there is a deficiency or a recognized indication; don’t chase a “high normal” number.

More is not better

Vitamin D toxicity “can cause hypercalcemia, hypercalciuria, and high serum 25(OH)D concentrations; in extreme cases, it may lead to renal failure, calcification of soft tissues, cardiac arrhythmias, and death,” and it “is almost always a result of excessive intakes of vitamin D through supplements” (NIH ODS). It is fat-soluble and accumulates. A provider who prescribes it should be able to tell you your starting level, the target, and when the next level will be drawn.

Pills vs. injections

Oral vitamin D3 is the standard and is inexpensive. Injectable (intramuscular) vitamin D has a narrower role: when the gut can’t be relied on (fat-malabsorption conditions, bariatric surgery) or when daily adherence is the real barrier. It is not a stronger form. In a randomized pediatric trial comparing a single intramuscular 600,000 IU dose with a staggered oral course, “no difference was found in efficacy of the two regimens” (Mondal et al., J Trop Pediatr 2014). The route is a practical decision a provider makes with you.

How BioPeakRx handles it

Injectable vitamin D3 at BioPeakRx is dispensed by prescription after a licensed provider evaluates you — and that evaluation starts with your 25(OH)D level and a reason. If you are deficient or in a recognized group, your provider will choose the route and dose and schedule the follow-up level. If your level is already sufficient, the honest recommendation is to leave it alone, and we will say so. Injectable vitamin D3 is not listed on this site; if you want it considered, raise it at your evaluation — start at /find-your-starting-point/.

This article is education, not medical advice, and does not establish a provider–patient relationship.

Sources: NIH Office of Dietary Supplements — Vitamin D Fact Sheet for Health Professionals · Manson JE et al., N Engl J Med 2019 — VITAL (PMID 30415629) · Demay MB et al., J Clin Endocrinol Metab 2024 — Endocrine Society guideline (PMID 38828931) · Mondal K et al., J Trop Pediatr 2014 (PMID 24401754)